Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1790 (LINC01790) is a non-coding RNA gene characterized by its transcription from intergenic regions of the genome, never overlapping with protein-coding genes[1][3][5][7]. LINC01790 likely shares with other lincRNAs the functions of modulating gene expression, organizing chromatin, and participating in RNA-based regulation at the transcriptional level[5][7][9]. While some lincRNAs are known to play roles in disease processes such as cancer or development, there is currently no published evidence that LINC01790 is directly implicated in specific diseases, nor is it considered a direct therapeutic target or the subject of drug interaction studies[3][5][7]. LINC01790 is catalogued in databases such as GeneCards and BioGPS as a human lincRNA gene, with its primary function and clinical relevance remaining to be elucidated[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1790 (LINC01790).